Protective efficacy of orally delivered bovine milk immunoglobulin (BIgG) specific for the minor CFA/I [colonisation factor antigen I] fimbrial adhesin CfaE against challenge with H10407 enterotoxigenic E. coli [Escherichia coli] (ETEC) strain expressing CFA/I

Trial Profile

Protective efficacy of orally delivered bovine milk immunoglobulin (BIgG) specific for the minor CFA/I [colonisation factor antigen I] fimbrial adhesin CfaE against challenge with H10407 enterotoxigenic E. coli [Escherichia coli] (ETEC) strain expressing CFA/I

Completed
Phase of Trial: Phase I

Latest Information Update: 03 Nov 2017

At a glance

  • Drugs Bovine anti-Escherichia coli immunoglobulin (Primary)
  • Indications Escherichia coli infections
  • Focus Adverse reactions
  • Most Recent Events

    • 20 Mar 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top